Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Laura Maria Fogliatto"'
Autor:
Guilherme Rasia Bosi, Laura Maria Fogliatto, Tito Emilio Vanelli Costa, Kamila Castro Grokoski, Mariana Pinto Pereira, Nathan Bugs, Marco Kalil, Christina Fraga, Liane Esteves Daudt, Lucia Mariano da Rocha Silla
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 41, Iss 3, Pp 222-228 (2019)
Objective: To assess clinical outcomes of intolerant, relapsed or refractory patients who could not be treated with new tyrosine kinase inhibitors or experimental therapies. Methods: A retrospective cohort of 90 chronic myeloid leukemia patients in a
Externí odkaz:
https://doaj.org/article/35410a9a2b9f4a8887d3eaf9f18a140c
Autor:
Belinda Pinto Simões, Laura Maria Fogliatto, Leonardo Javier Arcuri, Marcelo Eduardo Zanella Capra
Publikováno v:
Revista Brasileira de Cancerologia, Vol 64, Iss 2 (2018)
Introdução: O filgrastim, que desempenha um papel fundamental na coleta de células progenitoras de sangue periférico (CPSP), está disponível há quase 25 anos, e existem vários biossimilares de filgrastim sendo comercializados. Objetivo: Avali
Externí odkaz:
https://doaj.org/article/f9f9d517593947879ec392434c6223f4
Autor:
Andreas Hochhaus, Delphine Réa, Carla Boquimpani, Yosuke Minami, Jorge E. Cortes, Timothy P. Hughes, Jane F. Apperley, Elza Lomaia, Sergey Voloshin, Anna Turkina, Dong-Wook Kim, Andre Abdo, Laura Maria Fogliatto, Philipp le Coutre, Koji Sasaki, Dennis Dong Hwan Kim, Susanne Saussele, Mario Annunziata, Naeem Chaudhri, Lynette Chee, Valentin García-Gutiérrez, Shruti Kapoor, Alex Allepuz, Sara Quenet, Véronique Bédoucha, Michael J. Mauro
Publikováno v:
Leukemia. 37:617-626
Asciminib, the first BCR::ABL1 inhibitor that Specifically Targets the ABL Myristoyl Pocket (STAMP), is approved worldwide for the treatment of adults with Philadelphia chromosome–positive chronic myeloid leukemia in chronic phase (CML-CP) treated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::925b1dff371f56d5e87a1cf9f4fe14f0
https://doi.org/10.1038/s41375-023-01829-9
https://doi.org/10.1038/s41375-023-01829-9
Autor:
Pier Luigi Zinzani, Catherine Thieblemont, Vladimir Melnichenko, Krimo Bouabdallah, Jan Walewski, Alejandro Majlis, Laura Maria Fogliatto, Alejandro Martin Garcia-Sancho, Beth Christian, Zafer Gulbas, Muhit Özcan, Guilherme Fleury Perini, Herve Ghesquieres, Margaret A. Shipp, Seth Thompson, Samhita Chakraborty, Patricia Marinello, Philippe Armand
Publikováno v:
Blood Journal.
Previous analyses of the phase 2 KEYNOTE-170 (NCT02576990) study demonstrated effective antitumor activity and acceptable safety of pembrolizumab 200 mg given every 3 weeks for up to 35 cycles (~2 years) in patients with relapsed/refractory (R/R) pri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a0e3dbcc07252f871f4e1fa0884c8e1e
https://doi.org/10.1182/blood.2022019340
https://doi.org/10.1182/blood.2022019340
Autor:
Jean-Jacques Kiladjian, David M Ross, Laura Maria Fogliatto, Lynda Foltz, Lambert Busque, Zhijian Xiao, Florian H. Heidel, Michael Koehler, Giuseppe A. Palumbo, Massimo Breccia, Norio Komatsu, Keita Kirito, Blanca Xicoy Cirici, Joaquin Martinez-Lopez, Alicia Rovo, Cheryl Petruk, Mike Zuurman, Laura Mirams, Abigail McMillan, Gavin Harper, Claire Harrison
Publikováno v:
Blood. 140:12162-12164
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6069f33049aa252481463292e57c4758
https://doi.org/10.1182/blood-2022-162516
https://doi.org/10.1182/blood-2022-162516
Autor:
Isabela Delfino Moreira, Carem Luana Machado Lessa, Gueverson Leonardo Gonçalves Rocha, Laura Dewes Schmitz, Viviane Schmitt Jahnke, Laura Maria Fogliatto, Maria Cristina Werlang, Liane Nanci Rotta
Publikováno v:
European journal of haematologyREFERENCES. 109(6)
Given the complex pathology of sickle cell anemia (SCA) and low adherence to hydroxyurea (HU) treatment, there is a need to seek parameters that identify recent changes in patient status. The advanced clinical parameters (ACPs) allow an early analysi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f6d96a83f3e5d35aa773a52f1dea99f3
https://pubmed.ncbi.nlm.nih.gov/36048130
https://pubmed.ncbi.nlm.nih.gov/36048130
Autor:
Maria Eduarda Krützmann, Ranieri Reichel Martini, Fernanda de Souza Guterres, Ramona Kohlrausch, Sandrine Comparsi Wagner, Vanessa Suñe Mattevi, Mayde Seadi Torriani, Laura Maria Fogliatto, Rafael Linden, Marina Venzon Antunes
Publikováno v:
Journal of pharmaceutical and biomedical analysis. 222
Chronic Myeloid Leukemia (CML) is a hematologic neoplasia, characterized as a proliferative disease of the hematopoietic system. Imatinib mesylate (IM), a selective tyrosine kinase inhibitor, is considered a first-line therapy for CML, indicated for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e8a54bd54472a8d9adfb919f0fcdb2f
https://pubmed.ncbi.nlm.nih.gov/36279845
https://pubmed.ncbi.nlm.nih.gov/36279845
Autor:
Giane Durigon, Leo Sekine, Juliana Pires Marafon Franz, Laura Maria Fogliatto, Lucia Mariano da Rocha Silla
Publikováno v:
Transfusion and Apheresis Science. :103741
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b848e9747b5166726202e98b81102f0b
https://doi.org/10.1016/j.transci.2023.103741
https://doi.org/10.1016/j.transci.2023.103741
Autor:
Jason Westin, Adam J. Olszewski, Laura Maria Fogliatto, Won-Seog Kim, Ho-Jin Shin, Hao Wu, Shen Yin, Song Pham, Elicia Penuel, Jing Jing, Michael C. Wei, Elizabeth L. Budde
Publikováno v:
Blood. 140:3771-3772
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5871a326a2d18cf096a96e69eba057f5
https://doi.org/10.1182/blood-2022-157710
https://doi.org/10.1182/blood-2022-157710
Autor:
Marcelo Pitombeira de Lacerda, Fernanda de Morais Marques, Verena Pfister, Flavia de Carvalho Parra, Vinicius Campos de Molla, Valeria Buccheri, Rafael Dezen Gaiolla, Laura Maria Fogliatto, Rodrigo Santucci, Marcelo Bellesso, Sérgio Costa Fortier, Talita M.B. Silveira, Glaciano Ribeiro, Nelson Hamerschlak, Mihoko Yamamoto, Matheus Vescovi Goncalves, Carlos S. Chiattone, Celso Arrais-Rodrigues
Publikováno v:
Blood. 140:7041-7042
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b1a4330b42b325ddb5d48560c7840d07
https://doi.org/10.1182/blood-2022-170872
https://doi.org/10.1182/blood-2022-170872